Literature DB >> 35142571

Cortical lesion hotspots and association of subpial lesions with disability in multiple sclerosis.

Erin S Beck1, Josefina Maranzano2, Nicholas J Luciano3, Prasanna Parvathaneni3, Stefano Filippini3,4, Mark Morrison3, Daniel J Suto3, Tianxia Wu3, Peter van Gelderen3, Jacco A de Zwart3, Samson Antel5, Dumitru Fetco5, Joan Ohayon3, Frances Andrada3, Yair Mina3,6, Chevaz Thomas3, Steve Jacobson3, Jeff Duyn3, Irene Cortese3, Sridar Narayanan5, Govind Nair3, Pascal Sati3,7, Daniel S Reich3.   

Abstract

BACKGROUND: Dramatic improvements in visualization of cortical (especially subpial) multiple sclerosis (MS) lesions allow assessment of impact on clinical course.
OBJECTIVE: Characterize cortical lesions by 7 tesla (T) T2*-/T1-weighted magnetic resonance imaging (MRI); determine relationship with other MS pathology and contribution to disability.
METHODS: Sixty-four adults with MS (45 relapsing-remitting/19 progressive) underwent 3 T brain/spine MRI, 7 T brain MRI, and clinical testing.
RESULTS: Cortical lesions were found in 94% (progressive: median 56/range 2-203; relapsing-remitting: 15/0-168; p = 0.004). Lesion distribution across 50 cortical regions was nonuniform (p = 0.006), with highest lesion burden in supplementary motor cortex and highest prevalence in superior frontal gyrus. Leukocortical and white matter lesion volumes were strongly correlated (r = 0.58, p < 0.0001), while subpial and white matter lesion volumes were moderately correlated (r = 0.30, p = 0.002). Leukocortical (p = 0.02) but not subpial lesions (p = 0.40) were correlated with paramagnetic rim lesions; both were correlated with spinal cord lesions (p = 0.01). Cortical lesion volumes (total and subtypes) were correlated with expanded disability status scale, 25-foot timed walk, nine-hole peg test, and symbol digit modality test scores.
CONCLUSION: Cortical lesions are highly prevalent and are associated with disability and progressive disease. Subpial lesion burden is not strongly correlated with white matter lesions, suggesting differences in inflammation and repair mechanisms.

Entities:  

Keywords:  7 tesla MRI; Multiple sclerosis; cortical lesions

Mesh:

Year:  2022        PMID: 35142571      PMCID: PMC9256754          DOI: 10.1177/13524585211069167

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   5.855


  39 in total

1.  A global optimisation method for robust affine registration of brain images.

Authors:  M Jenkinson; S Smith
Journal:  Med Image Anal       Date:  2001-06       Impact factor: 8.545

2.  Focal cortical lesion detection in multiple sclerosis: 3 Tesla DIR versus 7 Tesla FLASH-T2.

Authors:  A Scott Nielsen; R Philip Kinkel; Emanuele Tinelli; Thomas Benner; Julien Cohen-Adad; Caterina Mainero
Journal:  J Magn Reson Imaging       Date:  2011-11-01       Impact factor: 4.813

3.  Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.

Authors:  Niraj Mistry; Rasha Abdel-Fahim; Olivier Mougin; Christopher Tench; Penny Gowland; Nikos Evangelou
Journal:  Mult Scler       Date:  2013-07-15       Impact factor: 6.312

4.  Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Authors:  R H S R Roxburgh; S R Seaman; T Masterman; A E Hensiek; S J Sawcer; S Vukusic; I Achiti; C Confavreux; M Coustans; E le Page; G Edan; G V McDonnell; S Hawkins; M Trojano; M Liguori; E Cocco; M G Marrosu; F Tesser; M A Leone; A Weber; F Zipp; B Miterski; J T Epplen; A Oturai; P Soelberg Sørensen; E G Celius; N Téllez Lara; X Montalban; P Villoslada; A M Silva; M Marta; I Leite; B Dubois; J Rubio; H Butzkueven; T Kilpatrick; M P Mycko; K W Selmaj; M E Rio; M Sá; G Salemi; G Savettieri; J Hillert; D A S Compston
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

Review 5.  Language disorders in multiple sclerosis: A systematic review.

Authors:  Stéphanie Renauld; Lyakout Mohamed-Saïd; Joël Macoir
Journal:  Mult Scler Relat Disord       Date:  2016-09-28       Impact factor: 4.339

6.  Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.

Authors:  A Scott Nielsen; Revere P Kinkel; Nancy Madigan; Emanuele Tinelli; Thomas Benner; Caterina Mainero
Journal:  Neurology       Date:  2013-07-17       Impact factor: 9.910

7.  Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis.

Authors:  D Pareto; J Sastre-Garriga; C Auger; Y Vives-Gilabert; J Delgado; M Tintoré; X Montalban; A Rovira
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-08       Impact factor: 3.825

8.  7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions.

Authors:  Jonathan Zurawski; Shahamat Tauhid; Renxin Chu; Fariha Khalid; Brian C Healy; Howard L Weiner; Rohit Bakshi
Journal:  Mult Scler       Date:  2019-11-12       Impact factor: 6.312

9.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

Authors:  Roberta Magliozzi; Owain Howell; Abhilash Vora; Barbara Serafini; Richard Nicholas; Maria Puopolo; Richard Reynolds; Francesca Aloisi
Journal:  Brain       Date:  2007-04       Impact factor: 13.501

10.  The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2* mapping at 7 T MRI.

Authors:  Céline Louapre; Sindhuja T Govindarajan; Costanza Giannì; Nancy Madigan; A Scott Nielsen; Jacob A Sloane; Revere P Kinkel; Caterina Mainero
Journal:  Neuroimage Clin       Date:  2016-11-03       Impact factor: 4.881

View more
  1 in total

1.  Multiple sclerosis cortical lesion detection with deep learning at ultra-high-field MRI.

Authors:  Francesco La Rosa; Erin S Beck; Josefina Maranzano; Ramona-Alexandra Todea; Peter van Gelderen; Jacco A de Zwart; Nicholas J Luciano; Jeff H Duyn; Jean-Philippe Thiran; Cristina Granziera; Daniel S Reich; Pascal Sati; Meritxell Bach Cuadra
Journal:  NMR Biomed       Date:  2022-03-31       Impact factor: 4.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.